Related Experiment Video
Updated: Sep 21, 2025

09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.6K
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data.
Seymour M Lopez1, Leon M Aksman1,2, Neil P Oxtoby3
1Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Epilepsia
|June 3, 2022
Summary
Researchers mapped the progression of brain changes in mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE-HS) using MRI. This sequence of neuroimaging alterations correlates with epilepsy duration, age at onset, and medication resistance, aiding in disease staging.
Area of Science:
- Neuroimaging
- Epilepsy Research
- Brain Morphology
Background:
- Common epilepsies exhibit characteristic, potentially progressive cortical thinning patterns.
- Previous studies suggest sequential changes in brain structure in epilepsy.
Purpose of the Study:
- To investigate the sequential nature of regional morphometric changes in mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE-HS).
- To correlate these neuroimaging changes with clinical features of MTLE-HS.
Main Methods:
- Utilized T1-weighted MRI scans from 804 MTLE-HS patients and 1625 controls from the ENIGMA-Epilepsy consortium.
- Employed an event-based model (EBM) trained on regional brain measures (cortical thickness, surface area, subcortical volumes) with Cohen's d ≥ 0.5.
- Assessed associations between EBM-derived disease stage and epilepsy duration, age at onset, and antiseizure medicine (ASM) resistance.
Main Results:
- Identified a sequence of brain changes in MTLE-HS: hippocampal volume reduction/asymmetry, followed by neocortical thinning, thalamus volume reduction, and ventricle enlargement.
- EBM stage correlated significantly with illness duration (ρ = 0.293), age at onset (ρ = -0.18), and ASM resistance (AUC = 0.59).
- Associations were primarily driven by early-stage MTLE-HS (EBM Stage 0) with subtle MRI abnormalities.
Conclusions:
- Reconstructed a cross-sectional MRI-based disease progression model for MTLE-HS, aligning with longitudinal findings.
- The developed model can stage MTLE-HS patients in new cohorts.
- This imaging-based staging can help link disease progression to clinical characteristics.

